Hepatoprotective mechanism of tauroursodeoxycholic acid and its therapeutic potential in liver diseases
Frontiers in Pharmacology · 29.10.2026 · 17
DOI: 10.3389/fphar.2026.1949645 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.10.2026. Verfasst von Ruting Chao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Xi'an Medical University, Xi'an, China. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tauroursodeoxycholic acid (TUDCA) is a natural hydrophilic secondary bile acid that acts as an effective chemical chaperone and exerts dramatically hepatoprotective effects. It alleviates endoplasmic reticulum stress (ERS), regulates the unfolded protein response (UPR), suppresses inflammatory responses, reduces oxidative stress, and inhibits hepatocyte apoptosis. In addition, TUDCA maintains bile acid metabolism homeostasis and modulates the gut–liver axis, showing significant therapeutic potential in multiple liver disorders, including metabolic dysfunction-associated steatotic liver disease (MASLD), cholestatic liver injury, liver fibrosis, hepatocellular carcinoma (HCC), hepatic ischemia–reperfusion injury (IRI). Despite promising preclinical evidence, the specific crosstalk between TUDCA and the gut microbiota remains largely unclear, and high-quality clinical evidence supporting its translation into clinical practice is still limited. This narrative review summarises the molecular targets and signaling pathways of TUDCA, discusses current research gaps, and provides a theoretical foundation for its rational clinical application and future mechanistic studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
- Graduate School of Xi'an Medical University, Xi'an, China.
Zitieren
APA
Chao, R., Zhang, Y., Hao, Y., Zhang, H., Zhang, M., & Sun, C. (2026). Hepatoprotective mechanism of tauroursodeoxycholic acid and its therapeutic potential in liver diseases. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1949645
Vancouver
Chao R, Zhang Y, Hao Y, Zhang H, Zhang M, Sun C. Hepatoprotective mechanism of tauroursodeoxycholic acid and its therapeutic potential in liver diseases. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1949645
BibTeX
@article{Chao2026,
author = {Chao, Ruting and Zhang, Yanan and Hao, Yuanzhu and Zhang, Huihui and Zhang, Mingxin and Sun, Chao},
title = {Hepatoprotective mechanism of tauroursodeoxycholic acid and its therapeutic potential in liver diseases},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1949645}
}
EUVIMED